This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hoganson, D. K. Articles by Boucher, R. C. Search for Related Content PubMed PubMed Citation Articles by Hoganson, D. K. Articles by Boucher, R. C.

Comparison of the Effects of Three Different Toxin Genes and Their Levels of Expression on Cell Growth and Bystander Effect in Lung Adenocarcinoma¹

Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7248

Transduction of malignant cells with toxin genes provides a novel means to promote tumor cell destruction. The efficacy of a toxin gene is dependent on the cell type targeted, the quantity of exogenous protein synthesized, and the mechanisms of growth inhibition and bystander killing. To develop gene therapy for targeting metastatic lung adenocarcinoma, the toxic activity of herpes simplex virus type 1-thymidine kinase, Escherichia coli cytosine deaminase, and human deoxycytidine kinase were investigated in metastatic human lung adenocarcinoma cell lines H1437 and H2122. Cells were transduced stably with retroviral vectors containing the toxin gene cDNA under the control of either a strong [cytomegalovirus (CMV) immediate early promoter and enhancer] or an intermediate strength (Moloney murine leukemia virus long terminal repeat) promoter. A comparison of toxin gene efficacy was based on the level of specific enzyme activity, the concentration of prodrug required to inhibit cell growth by 50%, and the magnitude of the bystander effect. In lung adenocarcinoma cell lines, cytosine deaminase, driven by the CMV promoter, was superior to thymidine kinase and deoxycytidine kinase in its ability to achieve high levels of specific enzyme activity, to induce growth inhibition, and to affect neighboring cell growth. Therefore, cytosine deaminase expressed from the CMV promoter seems to be the most promising toxin gene for human lung adenocarcinoma gene therapy.

¹ This work was supported by Glaxo-Wellcome Co. D. K. H. was supported by NIH Training Grant HL51818-02.

² To whom requests for reprints should be addressed, at CF/Pulmonary Research and Treatment Center, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7248. Phone: (919) 966-1077; Fax: (919) 966-7524.

Received 8/21/95. Accepted 1/17/96.

This article has been cited by other articles:

				D. Xu, D. Falke, and R. L. Juliano P53-Dependent Cell-Killing by Selective Repression of Thymidine Kinase and Reduced Prodrug Activation Mol. Pharmacol., August 1, 2003; 64(2): 289 - 297. [Abstract] [Full Text] [PDF]

				M. E. Black, M. S. Kokoris, and P. Sabo Herpes Simplex Virus-1 Thymidine Kinase Mutants Created by Semi-Random Sequence Mutagenesis Improve Prodrug-mediated Tumor Cell Killing Cancer Res., April 1, 2001; 61(7): 3022 - 3026. [Abstract] [Full Text]

				E. Kievit, M. K. Nyati, E. Ng, L. D. Stegman, J. Parsels, B. D. Ross, A. Rehemtulla, and T. S. Lawrence Yeast Cytosine Deaminase Improves Radiosensitization and Bystander Effect by 5-Fluorocytosine of Human Colorectal Cancer Xenografts Cancer Res., December 1, 2000; 60(23): 6649 - 6655. [Abstract] [Full Text]

				P. Erbs, E. Regulier, J. Kintz, P. Leroy, Y. Poitevin, F. Exinger, R. Jund, and M. Mehtali In Vivo Cancer Gene Therapy by Adenovirus-mediated Transfer of a Bifunctional Yeast Cytosine Deaminase/Uracil Phosphoribosyltransferase Fusion Gene Cancer Res., July 1, 2000; 60(14): 3813 - 3822. [Abstract] [Full Text]

				R. K. Batra, D. C. Guttridge, D. A. Brenner, S. M. Dubinett, A. S. Baldwin, and R. C. Boucher Ikappa Balpha Gene Transfer Is Cytotoxic to Squamous-Cell Lung Cancer Cells and Sensitizes Them to Tumor Necrosis Factor-alpha -Mediated Cell Death Am. J. Respir. Cell Mol. Biol., August 1, 1999; 21(2): 238 - 245. [Abstract] [Full Text]

				M. F. X. Gnant, M. Puhlmann, H. R. Alexander Jr., and D. L. Bartlett Systemic Administration of a Recombinant Vaccinia Virus Expressing the Cytosine Deaminase Gene and Subsequent Treatment with 5-Fluorocytosine Leads to Tumor-specific Gene Expression and Prolongation of Survival in Mice Cancer Res., July 1, 1999; 59(14): 3396 - 3403. [Abstract] [Full Text] [PDF]

				E. Nishihara, Y. Nagayama, F. Mawatari, K. Tanaka, H. Namba, M. Niwa, and S. Yamashita Retrovirus-Mediated Herpes Simplex Virus Thymidine Kinase Gene Transduction Renders Human Thyroid Carcinoma Cell Lines Sensitive to Ganciclovir and Radiation in Vitro and in Vivo Endocrinology, November 1, 1997; 138(11): 4577 - 4583. [Abstract] [Full Text] [PDF]